A5060198335- COVID-19 Clinical Research Studies
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Long-Term Effects of COVID-19
- Respiratory Support and Mechanisms
- Clinical practice guidelines implementation
- Influenza Virus Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
- Sepsis Diagnosis and Treatment
- Nosocomial Infections in ICU
- COVID-19 and healthcare impacts
- Cystic Fibrosis Research Advances
- Transplantation: Methods and Outcomes
- Syphilis Diagnosis and Treatment
- Fungal Infections and Studies
- Tattoo and Body Piercing Complications
- Pneumocystis jirovecii pneumonia detection and treatment
- Body Image and Dysmorphia Studies
- Cardiac Arrest and Resuscitation
- Mosquito-borne diseases and control
- COVID-19 and Mental Health
- Clinical Reasoning and Diagnostic Skills
- Inhalation and Respiratory Drug Delivery
- Dermatological and COVID-19 studies
Health Research Institute of the Balearic Islands
2025
Vall d'Hebron Institut de Recerca
2020-2024
Hospital Universitario Araba
2022-2024
Hospital Universitario Virgen del Rocío
2024
Hospital Materno-Infantil
2024
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias
2019-2023
Instituto de Salud Carlos III
2019-2023
Ospedale Policlinico San Martino
2020
European Society of Intensive Care Medicine
2020
Clinical Research Consortium
2020
The aim of this document was to develop standardized research definitions invasive fungal diseases (IFD) in non-neutropenic, adult patients without classical host factors for IFD, admitted intensive care units (ICUs). After a systematic assessment the diagnostic performance IFD target population already existing and laboratory tests, consensus were developed by panel experts using RAND/UCLA appropriateness method. Standardized proven candidiasis, probable deep-seated aspergillosis, pulmonary...